Text Size

Impact of Three Continuing Education Meetings for Community Pharmacists on Weight Management

This study has been completed.
Sponsor:
Information provided by:
Tehran University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01339364
First received: April 15, 2011
Last updated: July 25, 2011
Last verified: July 2011
History of Changes
  Purpose

This study is a three-arm randomized controlled trial to evaluate the effects of 1-day continuing educational meetings for community pharmacists with three distinct educational methods: 1) Didactic lecture 2) Didactic lecture plus case discussion in a large group 3) Didactic lecture plus small group education with simulated patient

Knowledge and attitude of the participants would be measured as the study outcome in three periods: pre-education, post-education and 1 month after the meetings.


Condition Intervention
Continuing Pharmacy Education
Obesity
 Other: Didactic Lecture
Other: Interactive Lecture
Other: Lecture plus Small Group Education

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Caregiver)
Primary Purpose: Health Services Research
Official Title: Evaluation of Three 1-day Educational Intervention to Promote Knowledge and Attitude of Community Pharmacists About Evidence-based Weight Management

Resource links provided by NLM:

MedlinePlus related topics: Obesity
U.S. FDA Resources

Further study details as provided by Tehran University of Medical Sciences:

Primary Outcome Measures:
  • Knowledge Grade Points and Attitudes(Phase 1) [ Time Frame: One day ] [ Designated as safety issue: No ]
    Obtained through a validated knowledge and attitude questionnaire.

  • Knowledge Grade Points and Attitudes(Phase 2) [ Time Frame: One month(average of 4 weeks after the day of training) ] [ Designated as safety issue: No ]
    Obtained through a validated knowledge and attitude questionnaire.


Secondary Outcome Measures:
  • Satisfaction of Participants [ Time Frame: One day ] [ Designated as safety issue: No ]
    Obtained by a Satisfaction Evaluation Questionnaire.


Estimated Enrollment: 180
Study Start Date: January 2011
Study Completion Date: June 2011
Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Didactic Lecture Other: Didactic Lecture
2 sessions of didactic lecture with PowerPoint presentations each delivered by a special lecturer. whole education period lasts 3 hours.
Experimental: Lecture plus Case Disscussion Other: Interactive Lecture
2 sessions of brief interactive lectures followed by case discussion sections.
Experimental: Lecture plus Small Group Education Other: Lecture plus Small Group Education
A 1.5 hours session of didactic lecture followed by a session of small group education with 3 simulated patients.

Detailed Description:

The study is designed as an Instructor blinded-Randomized Controlled Trial.

An educational need assessment is undergone prior to educational content preparation by interviewing 5 community pharmacists. After educational content preparation by instructors, the outcome assessment tool (knowledge, attitude questionnaire) would be designed by a distinct investigator. Closed and Open-ended questions are included to investigate different levels of Bloom's taxonomy.

The questionnaire would be validated by specialists other than the instructors and it will piloted to investigate the reliability( Cronbach's Alfa > 0.7).

Community pharmacists of Tehran,Capital city of Iran, would be invited to participate in the study. The participants would be randomly assigned to 3 groups by random number table. Each group receives the same education content with a different method:

  1. Didactic lecture
  2. Didactic lecture plus case discussion in a large group
  3. Didactic lecture plus small group education with simulated patient(SP). Interviewing with SP is conducted by small group facilitators with Brain Storming Technic.

Each participant receives a compact disk which includes the educational material and he/she would be able to contact the instructors by phone or e-mail during the follow-up period. (Reinforcement Phase)

  Eligibility

Ages Eligible for Study:   25 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Community Pharmacist

Exclusion Criteria:

  • Less than four hours of daily work in community pharmacy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01339364

Locations
Iran, Islamic Republic of
Faculty of Pharmacy-Tehran University of Medical Sciences
Tehran, Iran, Islamic Republic of
Sponsors and Collaborators
Tehran University of Medical Sciences
Investigators
Study Chair: Kheirollah Gholami, M.Sc, PharmD Tehran University of Medical Sciences
Principal Investigator: Arash Rashidian, MD, PhD Tehran University of Medical Sciences
Principal Investigator: Mohammadreza Javadi, PharmD, BCPS Tehran University of Medical Sciences
Principal Investigator: Amir Sarayani, PharmD, MPH Tehran University of Medical Sciences
  More Information

No publications provided

Responsible Party: Kheirollah Gholami M.Sc., PharmD, Tehran University of Medical Sciences
ClinicalTrials.gov Identifier: NCT01339364     History of Changes
Other Study ID Numbers: 240/4402
Study First Received: April 15, 2011
Last Updated: July 25, 2011
Health Authority: Iran: Ministry of Health

Additional relevant MeSH terms:
Obesity
Overnutrition
Nutrition Disorders
 Overweight
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on May 16, 2013